Abstract
We examined the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and cefmetazole sodium on survival, neutrophil count, and neutrophil function in rats with peritonitis produced by cecal ligation and puncture. Rats with peritonitis received either rhG-CSF (50 or 100 μg/kg) with or without cefmetazole (50 mg/kg) for 3 days, cefmetazole alone, or no treatment and were evaluated as controls. The mortality rate of all treated rats was significantly lower than that of the untreated rats. The survival rate was 57.1% for the rats given both rhG-CSF and cefmetazole, but there was no significant improvement of survival as compared with cefmetazole therapy alone. Treatment with rhG-CSF at 100 |Gmg/kg caused the circulating neutrophil count to increase significantly. The phagocytic activity for latex beads and neutrophil H2O2 production showed a greater enhancement by phorbol myristate acetate (PMA) in the untreated rats, thus indicating that neutrophils from treated rats were more activated. These findings show that rhG-CSF can improve survival and neutrophil function in rats with peritonitis, while combined therapy with cefmetazole was also found to be beneficial.
Similar content being viewed by others
References
Sullivan GW, Mandell GL (1986) The role of cytokines in infection. Curr Opin Infect Dis 4:344–349
Sartorelli KH, Silver GM, Gamelli RL (1991) The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis. J Trauma 31:523–530
Lang CH, Gregory GJ, Dobrescu C, Nelson S, Spitzer JJ (1992) Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis 166:336–343
Issekutz AC, Movat HZ (1980) The in vivo quantitation and kinetics of neutrophil leukocyte accumulation in skin in response to chemotactic agents and Escherichia coli. Lab Invest 42:310–317
Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J (1991) Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanoltreated rats. J Infect Dis 164:901–906
McEuen DD, Ogawa M, Eurenius K (1977) Myelopoiesis in the infected burn. J Lab Clin Med 89:540–543
Newsome TW, Eurenius K (1973) Suppression of granulocyte and platelet production by Pseudomonas burn wound infection. Surg Gynecol Obstet 136:375–379
Welte K, Bonilla MA, Gabrilove JL, Gillio AP, Potter GK, Moore MAS, O'Reilly RJ, Boone TC, Souza LM (1987) Recombinant human granulocyte colony-stimulating factor: In vitro and in vivo effects on myelopoiesis. Blood Cells 13:17–30
Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MAS (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82:1526–1530
Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK, Barendt J, Platzer E, Moore MAS, Mertelsmann R, Welte K (1986) Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61–65
Schriber JR, Negrin RS. Use and toxicity of the colony-stimulating factors (1993) Drug Safety 8:457–468
Cohen AM, Hines DK, Korach ES, Ratzkin BJ (1988) In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor. Infect Immun 56:2861–2865
Matsumoto M, Matsubara S, Matsuno T, Tamura M, Hattori K, Nomura H, Ono M, Yokota T (1987) Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 55:2715–2720
Yasuda H, Ajiki Y, Shimozato T, Kasahara M, Kawada H, Iwata M, Shimizu K (1990) Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun 58:2502–2509
Wakiyama H, Tsuru S, Hata N, Shinomiya M, Shinomiya N, Noritake M, Umezawa Y, Rokutanda M (1993) Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide. Clin Exp Immunol 92:218–224
Matsumoto F, Imai T, Takahashi T, Taura Y, Kokubo K, Sakurai I, Katopu N, Murata T (1989) Influence of β-lactam antibiotics at sub-MIC concentrations on the adherence of Escherichia coli and phagocytosis and killing by human PMN (in Japanese with English abstract). Chemotherapy (Tokyo) 37:1321–1326
Rodriguez AB, Barriga C, De La Fuente M (1991) Stimulation of phagocytic processes and antibody-dependent cellular cytotoxicity of human neutrophils by cefmetazole. Microbial Immunol 35:545–556
Matsumoto M, Matsubara S, Yokota T (1991) Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. JAC 28:447–453
Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock — A review of laboratory models and a proposal. J Surg Res 29:189–201
Dunn PA, Tyrer HW (1981) Quantitation of neutrophil phagocytosis using fluorescent latex beads. J Lab Clin Med 98:374–381
Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J Immunol 130:1910–1917
Pauw BE (1990) Treatment of infection in neutropenia. Curr Opin Infect Dis 3:197–202
Kaushansky K, Lin N, Adamson JW (1988) Interleukin-1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors: Mechanism for the hematopoietic response to inflammation. J Clin Invest 81:92–97
Mooney DP, Gamelli RL, O'Reilly M, Hebert JC (1988) Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg 123:1353–1357
Sieff CA (1987) Hematopoietic growth factors. J Clin Invest 79:1549–1557
Kawakami M, Tsutsumi H, Kumakawa T, Abe H, Hirai M, Kurosawa S, Mori M, Fukushima M (1990) Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962–1964
Toda H, Murata A, Matsuura N, Uda K, Oka Y, Tanaka T, Mori T (1993) Therapeutic efficacy of granulocyte colony-stimulating factor against rat cecal ligation and puncture model. Stem Cells 11:228–234
Clark SC, Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236:1229–1237
Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takaku F (1987) Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun 144:1143–1146
O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC (1992) Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 33:679–682
Silver GM, Gamelli RL, O'Reilly M (1989) The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 106:452–456
Toda T, Murata A, Oka Y, Uda K, Tanaka N, Ohashi I, Matsuura N (1994) Effect of granulocyte-macrophage colony-stimulating factor on sepsis-induced organ injury in rats. Blood 83:2893–2898
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishikura, H., Uedono, Y., Yamagami, K. et al. Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis. Surg Today 26, 694–699 (1996). https://doi.org/10.1007/BF00312086
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00312086